FDA Greenlights Bayer-Loxo’s Vitrakvi

05.12.2018 - A new type of cancer treatment developed by a partnership of Bayer with biotech partner Loxo Oncology has won approval from the US Food and Drug Administration (FDA). Vitrakvi is...